Business Context and Reporting Period
This Form 8-K Current Report was filed by Globus Medical, Inc. on February 5, 2024. The report discloses a material corporate governance event regarding the appointment of a senior executive officer, effective February 1, 2024.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation adjustments.
Material Changes
The primary material change reported is the promotion of Keith Pfeil to the roles of Chief Operating Officer (COO) and Chief Financial Officer (CFO), effective February 1, 2024. Mr. Pfeil previously served as Senior Vice President and CFO since August 2019.
Associated compensation changes include:
- Base Salary: Increased from $414,690 to $460,000.
- Target Bonus: Increased from $325,000 to $600,000 under the annual non-equity incentive compensation program.
- Proration: Both increases are prorated for the portion of the year Mr. Pfeil serves in the expanded role.
All other terms of his existing employment agreement remain unchanged.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or discussion of operational risks. It confirms there are no undisclosed relationships or arrangements requiring disclosure under Regulation S-K regarding Mr. Pfeil's appointment.
Investor Verification Checklist
- Verify the effective date of the COO/CFO promotion (February 1, 2024).
- Confirm the specific salary and bonus adjustments for Keith Pfeil.
- Review the attached press release (Exhibit 99.1) for additional context on the leadership transition.
- Note that this filing does not provide updated financial results; refer to the most recent 10-K or 10-Q for financial metrics.